Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

An oncology-focused Pfizer is poised to grow over the coming years. Abundant (and growing) earnings protect the dividend despite an abnormally high yield. The stock's valuation signals that the ...

Be among those who shape the future with knowledge. Uncover exclusive stories that captivate your mind and heart with our FREE 14-day subscription trial. Dive into a world of inspiration, learning, ...

Marsha's career included working for Portage Northern High School and the Upjohn Company, which later became Pharmacia/Pfizer. However, her greatest accomplishment was the family she raised with love ...

Three students from Centreville High School in Clifton discovered a potentially harmful substance – DNA residues, or tiny fragments of genetic material – in Pfizer’s messenger RNA COVID-19 ...

However, at least two conditions listed as adverse events also appeared in Pfizer's 2024 list of genuine side effects. In January 2025, Snopes readers asked us about the authenticity of a long ...

NAIROBI, Kenya Jan 16 – Biotech and pharmaceutical company Pfizer has announced plans to reorganise its activities in Kenya amid emerging market dynamics. A company spokesperson said the ...

(Bloomberg) -- Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste. The deal raised around £2.5 billion ($3.1 billion ...

Pfizer PFE-2.06%decrease; red down pointing triangle has sold 700 million shares in British consumer-healthcare business Haleon HLN-0.11%decrease; red down pointing triangle for 2.50 billion ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I think we did significant transformative changes in Pfizer.” ...

Pfizer saved $4 billion, plans $1.5 billion more in margin improvements, and issued $7 billion in dividends in nine months. Acquisitions are projected to offset $17 billion-18 billion in revenue ...

In separate presentations, the CEOs of Bristol Myers Squibb, Pfizer and Merck laid out their plans to overcome high-profile losses of exclusivity (LOEs) slated to dent sales through the end of the ...